Latest Cash Flow Improvement News

Cochlear Limited reported a modest 1% rise in sales but a 9% fall in underlying net profit for the half year ended December 2025, as the rollout of its innovative Nucleus Nexa System faced longer-than-expected regulatory and contract hurdles. The company anticipates a robust second half driven by broader product availability and service growth.

Cochlear Limited posted a modest 1% increase in sales revenue for the half year ending December 2025, while underlying net profit fell 9%, impacted by cloud computing costs and a slower-than-expected Nexa System rollout. The company maintains its dividend and outlines cautious FY26 guidance.

Elixinol Wellness reported a 9.5% revenue increase in Q4 FY25 alongside a 30% reduction in operating costs, setting a clear path to profitability under fresh executive leadership.

Origin Energy reported robust half-year results for December 2025, driven by strong Energy Markets performance and significant customer growth, while updating FY26 guidance with higher earnings expectations.

News Corporation reported a 4% revenue increase to US$4.506 billion for the half-year ended December 2025, while net income declined 9% to US$305 million. The company declared an interim dividend and continued its stock repurchase program amid mixed segment performances and ongoing legal challenges.

A single exploration name blew the doors off the leaderboard, while two well-known uranium plays and a Nevada explorer sank hard. Behind the noise: deals got closer to completion, big raisings reset prices, and several “good news” gaps didn’t survive the week.

A single diagnostics update sparked a breakout week, while a handful of biotech names sold off hard despite busy newsflow. Capital raisings, takeover steps and US market pushes kept healthcare in motion heading into mid-February milestones.

FlexiRoam Limited reveals a strong financial turnaround with AI-powered innovations driving profitability and margin expansion in the first half of FY26. The company’s strategic partnerships and zero-integration platform position it well in the fast-growing eSIM market.

Ryman Healthcare has unveiled a refreshed strategy focused on growing recurring earnings and optimising its portfolio, targeting a $150 million sustainable cash flow improvement and $500 million cash release by FY29. The company plans to resume dividends from FY28, underpinned by a resilient balance sheet and disciplined capital management.

Australian Bond Exchange Holdings (ABE) has successfully completed live testing in the Reserve Bank of Australia's CBDC pilot, expanded its product offerings, and reported improved cash flow in Q2 FY26.

Opthea Limited has streamlined its operations with a NASDAQ delisting and completed a strategic review, positioning itself to advance the OPT-302 treatment for LAM with a robust cash position.

Pentanet has reported steady growth in Q2FY26, driven by a strong 5G revenue jump and sustained positive earnings before interest, tax, depreciation, and amortisation (EBITDA). The company’s new brand campaign and subscriber gains signal a strategic push into the second half of the fiscal year.